SOX6 and anemia (phenotype): In addition to Epo treatments widely used to generate an adequate burst of early erythroid cells in patients with various anemia-causing conditions, one should thus also consider targeting Sox6 to ensure timely maturation and release, as well as long life of newly generated red blood cells.